A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

For five years now, a bipartisan group of Illinois lawmakers have wanted to establish a Prescription Drug Affordability Board. But this year’s effort may hit the same wall as before.

PharmEasy is redefining healthcare delivery in India. In the inaugural episode of the Masters of CX - Season 3, CEO Siddharth Shah reveals how the company leverages technology to overcome geographical ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease The Food and Drug ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...